Surely, it won't be too long before the ASX is awakened to the true value of this company.
The combination of the soaring Daybue sales in NA and this deal (which in addition to ROW Daybue licencing also highlights the huge potential behind NNZ 2591) must poke the bear into unstoppable real action instead of the hitherto grinding and dreary algo manipulation.
IMO, the day when NEUREN receives the re-rating market attention that it richly deserves is just around the corner.
Ann: Neuren and Acadia expand global partnership for trofinetide, page-88
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.54 |
Change
0.100(0.80%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.44 | $12.73 | $12.13 | $11.07M | 885.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1215 | $12.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.54 | 804 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |